International Journal of Clinical Case Reports 2024, Vol.14, No.5, 276-289 http://medscipublisher.com/index.php/ijccr 288 Kimura N., Maffioletti V., Santos R., Baptista M., and Dourado M., 2015, Psychosocial impact of early onset dementia among caregivers, Trends in Psychiatry and Psychotherapy, 37(4): 213-219. https://doi.org/10.1590/2237-6089-2015-0038 PMID: 26689390 Lanoiselée H.M., Nicolas G., Wallon D., Rovelet-Lecrux A., Lacour M., Rousseau S., Richard A.C., Pasquier F., Rollin-Sillaire A., Martinaud O., Quillard-Muraine M., de la Sayette V., Boutoleau-Bretonniere C., Etcharry-Bouyx F., Chauviré V., Sarazin M., Ber I.l., Epelbaum S., Jonveaux T., Rouaud O., Ceccaldi M., Félician O., Godefroy O., Formaglio M., Croisile B., Auriacombe S., Chamard L., Vincent J.L., Sauvée M., Marelli-Tosi C., Gabelle A., Ozsancak C., Pariente J., Paquet C., Hannequin D., and Campion D., 2017, APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases, PLoS Medicine, 14(3): e1002270. https://doi.org/10.1371/journal.pmed.1002270 PMID: 28350801 PMCID: PMC5370101 Liu M., Xie X., Xie J.H., Tian S., Du X., Feng H., and Zhang H., 2023, Early-onset Alzheimer’s disease with depression as the first symptom: a case report with literature review, Frontiers in Psychiatry, 14: 1192562. https://doi.org/10.3389/fpsyt.2023.1192562 PMID: 37181906 PMCID: PMC10174310 Lombardi G., Crescioli G., Cavedo E., Lucenteforte E., Casazza G., Bellatorre A., and Filippini G., 2020, Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment, The Cochrane Database of Systematic Reviews, (3): CD009628. https://doi.org/10.1002/14651858.CD009628.pub2 PMID: 32119112 PMCID: PMC7059964 Mendez M., 2017, Early-onset alzheimer disease, Neurologic Clinics, 35(2): 263-281. https://doi.org/10.1016/j.ncl.2017.01.005 PMID: 28410659 PMCID: PMC5407192 Musa G., Slachevsky A., Muñoz-Neira C., Méndez C., Villagra R., González-Billault C., Ibáñez A., Hornberger M., and Lillo P., 2019, Alzheimer's disease or behavioral variant frontotemporal dementia? review of key points toward an accurate clinical and neuropsychological diagnosis, Journal of Alzheimer's Disease, 73(3): 833-848. https://doi.org/10.3233/JAD-190924 PMID: 31884475 PMCID: PMC7012749 Olsson B., Lautner R., Andreasson U., Ohrfelt A., Portelius E., Bjerke M., Holtta M., Rosén C., Olsson C., Strobel G., Wu E., Dakin K., Petzold M., Blennow K., and Zetterberg H., 2016, CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, The Lancet Neurology, 15(7): 673-684. https://doi.org/10.1016/S1474-4422(16)00070-3 PMID: 27068280 Palmqvist S., Zetterberg H., Mattsson N., Johansson P., Minthon L., Blennow K., Olsson M., and Hansson O., 2015, Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease, Neurology, 85: 1240-1249. https://doi.org/10.1212/WNL.0000000000001991 PMID: 26354982 PMCID: PMC4607601 Park J., Gunasekaran T., Cho Y., Choi S., Song M., Cho S., Kim J., Song H., Choi K., Lee J., Park Z., Song W., Jeong H., Lee K., Lee J., and Kim B., 2022, Diagnostic blood biomarkers in Alzheimer’s disease, Biomedicines, 10(1): 169. https://doi.org/10.3390/biomedicines10010169 PMID: 35052848 PMCID: PMC8773964 Rivero-Santana A., Ferreira D., Perestelo-Pérez L., Westman E., Wahlund L., Sarría A., and Serrano-Aguilar P., 2016, Cerebrospinal fluid biomarkers for the differential diagnosis between Alzheimer's disease and frontotemporal lobar degeneration: systematic review, hsroc analysis, and confounding factors, Journal of Alzheimer's Disease, 55(2): 625-644. https://doi.org/10.3233/JAD-160366 Shimada H., Minatani S., Takeuchi J., Takeda A., Kawabe J., Wada Y., Mawatari A., Watanabe Y., Shimada H., and Higuchi M., 2020, Heavy tau burden with subtle amyloid β accumulation in the cerebral cortex and cerebellum in a case of familial Alzheimer’s disease with app osaka mutation, Int. J. Mol. Sci., 21(12): 4443. https://doi.org/10.3390/ijms21124443 PMID: 32580499 PMCID: PMC7352205 Stocker H., Möllers T., Perna L., and Brenner H., 2018, The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores, Translational Psychiatry, 8(1): 166. https://doi.org/10.1038/s41398-018-0221-8 PMID: 30143603 PMCID: PMC6109140 Wang L.Y., Pei J., Zhan Y., and Cai Y., 2020, Overview of meta-analyses of five non-pharmacological interventions for Alzheimer's disease, Frontiers in Aging Neuroscience, 12: 594432. https://doi.org/10.3389/fnagi.2020.594432 PMID: 33324194 PMCID: PMC7723835
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==